UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in DNLI — Denali Therapeutics Inc.
CIK 861177
NEW YORK, NY
Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,325,915
-$3,774,510 QoQ
Shares Held
3,161,972
-28.7% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#13
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. DNLI ranks #10 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,325,915 | 3,161,972 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $85,100,425 | 4,432,314 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $82,281,312 | 4,983,726 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $79,352,332 | 5,465,037 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,609,251 | 6,262,277 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $91,996,218 | 6,766,916 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $73,018,967 | 3,582,874 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $109,222,524 | 3,749,486 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $53,352,960 | 2,297,716 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $14,102,140 | 687,239 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,200,951 | 708,339 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $13,271,276 | 643,300 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $16,736,329 | 567,141 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $13,066,926 | 567,141 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,126,495 | 543,923 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,271,956 | 530,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $14,344,323 | 487,405 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,988,382 | 434,827 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $19,625,603 | 440,036 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,932,327 | 434,734 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $33,719,079 | 429,871 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $17,032,014 | 298,284 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $34,315,046 | 409,683 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $17,732,516 | 494,907 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $11,912,735 | 492,669 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,158,128 | 66,141 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||